出版:MarketsandMarkets

バイオインフォマティクスサービス市場:タイプ(シーケンス、データ分析、発見、遺伝子発現、データベース管理)、専門領域(医療、工場、科学捜査)、用途(ゲノム科学、メタボロミクス)、エンドユーザ(学術、ファーマバイオテック)別の2026年までの世界市場予測

Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), Enduser (Academia, Pharma-biotech) – Global Forecast to 2026

出版 MarketsandMarkets
出版年月 2021年7月
ページ数 231
図表数 244
種別 英文調査報告書

レポート目次  お問合せ

MarketsandMarkets出版の当調査レポートは世界のバイオインフォマティクス市場を調査・分析し、2026年までの市場予測を行っています。

主な掲載内容

  • 市場概観
  • バイオインフォマティクスサービス市場 – タイプ別
    • シーケンスサービス
    • データマイニング
    • 創薬サービス
    • 差次的遺伝子発現解析
    • データベースと管理サービス
    • その他のバイオインフォマティクスサービス
  • バイオインフォマティクスサービス市場 – 専門領域別
    • 医用生体工学
    • 動物用バイオテクノロジー
    • 植物向けバイオテクノロジー
    • 環境向けバイオテクノロジー
    • 法医学向けバイオテクノロジー
  • バイオインフォマティクスサービス市場 – 用途別
  • バイオインフォマティクスサービス市場 – エンドユーザ別
  • バイオインフォマティクスサービス市場 – 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東&アフリカ
  • 競争環境
  • 企業情報
  • 別表

The bioinformatics services market is projected to reach USD 5.3 Billion by 2026 from USD 2.5 Billion in 2021, at a CAGR of 15.8% during the forecast period. Growing applications of bioinformatics across industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals (leading to increased outsourcing of bioinformatics projects) are the major factors that are expected to drive the growth of the bioinformatics services market during the forecast period. However, the in-house development of bioinformatics solutions and publicly available bioinformatics tools are expected to limit market are expected to restrain market growth in the coming years.

In terms Application, the genomics segment is expected to account for the largest share of the bioinformatics services market in 2020.

Based on application, the bioinformatics services market is segmented into genomics, chemoinformatics and drug design, proteomics, transcriptomics, metabolomics and other applications. Large share is attributed to genomics segment due to increasing use of pharmacogenomic research for the development of precision medicine, favorable funding scenario for genomic research, and partnerships and collaborations between various life sciences and informatics companies for the development of advanced bioinformatics solutions and services.

“In terms of type segment, sequencing services segment is expected to account for the largest share during the forecast period.”

Based on type, the bioinformatics services market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database and management services, and other bioinformatics services. Due to reduced cost of sequencing the sequencing services segment enjoy the major share of the market.

“In terms of specialty segment, medical biotechnology segment is expected to account for the largest share during the forecast period.”

Based on specialty, the bioinformatics services market is segmented into medical biotechnology, plant biotechnology, animal biotechnology, environment biotechnology and forensic biotechnology. Medical biotechnology holds the largest share due to the development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and increasing funding for the development of bioinformatics solutions for clinical diagnostics.

“The academic institutes and research centers segment is expected to register the highest CAGR during the forecast period”

Based on end-users, the bioinformatics services market has been segmented as —academic institiutes and research centers, hospitals and clinics, pharma and biotech companies, CROs and other end users. The large share of academic institutes and research centers segment can be attributed to the growing number of bioinformatics-based research studies, increasing scale of genomics research, rising number of collaborations between academic research institutes and players in the bioinformatics market, and the growing number of government funding programs for genomics research.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

The bioinformatics services market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region offered significant opportunities for the growth of the bioinformatics services market. The market growth in Asia Pacific can be attributed to the increasing incidence of genetic diseases, rising number of bioinformatics-based research studies, and growing demand for bioinformatics services from various end users.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
  • By Designation: C-level–10%, Director-level–14%, and Others–76%
  • By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

Prominent players in the bioinformatics services market include Illumina (US), Thermo Fisher Scientific (US), Eurofins Scientific (Luxembourg), BGI Group (China), NeoGenomics (US), PerkinElmer (US), CD Genomics (US), Psomagen, Inc. (South Korea), QIAGEN (Germany), GENEWIZ (US), Source BioScience (UK), Microsynth (Switzerland), MedGenome (India), Fios Genomics (UK), and BaseClear (Netherlands), among others.

Research Coverage

This report studies the bioinformatics services market based on type, specialty, application, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to five major regions and their respective major countries.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the services offered by the top players in the bioinformatics services market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the bioinformatics services market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the bioinformatics services market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.


目次

1 INTRODUCTION 31

1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 MARKET SCOPE 32
1.2.2 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.3 MARKETS COVERED 33
FIGURE 1 BIOINFORMATICS SERVICES MARKET SEGMENTATION 33
1.2.4 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 34
TABLE 1 STANDARD CURRENCY CONVERSION RATES 34
1.4 LIMITATIONS 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 36

2 RESEARCH METHODOLOGY 37

2.1 RESEARCH DATA 37
2.2 RESEARCH APPROACH 37
FIGURE 2 BIOINFORMATICS SERVICES MARKET: RESEARCH DESIGN METHODOLOGY 37
2.2.1 SECONDARY DATA 38
2.2.2 PRIMARY DATA 38
FIGURE 3 PRIMARY SOURCES 39
2.2.2.1 Key data from primary sources 40
2.2.2.2 Key industry insights 41
FIGURE 4 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.3 MARKET ESTIMATION METHODOLOGY 42
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 43
FIGURE 6 MARKET SIZE ESTIMATION: BIOINFORMATICS SERVICES
MARKET (BOTTOM-UP APPROACH) 44
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
FIGURE 8 TOP-DOWN APPROACH 45
2.4 COVID-19 HEALTH ASSESSMENT 46
2.5 COVID-19 ECONOMIC ASSESSMENT 46
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 46
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 47
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 48
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE BIOINFORMATICS SERVICES MARKET 48
2.8 DATA TRIANGULATION 49
FIGURE 11 DATA TRIANGULATION 49
2.9 RESEARCH ASSUMPTIONS 50
2.10 RISK ANALYSIS 50

3 EXECUTIVE SUMMARY 51

FIGURE 12 BIOINFORMATICS SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 51
FIGURE 13 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2021 VS. 2026 (USD MILLION) 52
FIGURE 14 BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 52
FIGURE 15 BIOINFORMATICS SERVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 53
FIGURE 16 BIOINFORMATICS SERVICES MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 54

4 PREMIUM INSIGHTS 55

4.1 BIOINFORMATICS SERVICES MARKET OVERVIEW 55
FIGURE 17 GROWING APPLICATIONS OF BIOINFORMATICS TO DRIVE
THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD 55
4.2 BIOINFORMATICS SERVICES MARKET, BY TYPE 56
FIGURE 18 SEQUENCING SERVICES SEGMENT WILL CONTINUE TO DOMINATE THE BIOINFORMATICS SERVICES MARKET BY 2026 56
4.3 ASIA PACIFIC BIOINFORMATICS SERVICES MARKET, BY COUNTRY AND APPLICATION 57
FIGURE 19 GENOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOINFORMATICS SERVICES MARKET 57
4.4 BIOINFORMATICS SERVICES MARKET, BY END USER 58
FIGURE 20 ACADEMIC INSTITUTES AND RESEARCH CENTERS ARE
THE LARGEST END USERS OF BIOINFORMATICS SERVICES 58
4.5 BIOINFORMATICS SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
FIGURE 21 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 58

5 MARKET OVERVIEW 59

5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 22 MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
5.2.1 DRIVERS 60
5.2.1.1 Growing applications of bioinformatics in various industries 60
5.2.1.2 Increasing public-private sector funding for bioinformatics services 60
TABLE 2 PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS 60
5.2.1.3 Shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects 63
5.2.1.4 Increasing pharmaceutical and biotech R&D expenditure 63
TABLE 3 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN THE ASIA PACIFIC REGION 64
5.2.2 RESTRAINTS 64
5.2.2.1 In-house development of bioinformatics solutions and publicly available bioinformatics tools 64
5.2.3 OPPORTUNITIES 65
5.2.3.1 Reducing cost of sequencing and growing volume of data generated during sequencing 65
FIGURE 23 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2019 65
FIGURE 24 DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING,
2001–2019 66
5.2.3.2 Growing focus on outsourcing for the management
of large volumes of data 66
5.2.3.3 Growth potential in emerging economies 67
5.2.4 CHALLENGES 67
5.2.4.1 Complexity of data 67
5.2.4.2 Lack of well-defined standards and interoperability issues for bioinformatics analysis 67
5.2.4.3 Ethical issues 68
5.2.5 INDUSTRY TRENDS 68
5.2.5.1 Partnerships & collaborations for technological advancements in the bioinformatics services market 68
FIGURE 25 ECOSYSTEM COVERAGE: PARENT MARKET 69
5.3 REGULATORY ANALYSIS 69
5.3.1 GLOBAL ALLIANCE FOR GENOMICS AND HEALTH (GA4GH) 69
5.4 VALUE CHAIN ANALYSIS 70
FIGURE 26 VALUE CHAIN: BIOINFORMATICS SERVICES WORKFLOW—
ANALYSIS PLAYS A CRUCIAL ROLE AFTER CORE SERVICES 70
5.5 SUPPLY CHAIN ANALYSIS 70
TABLE 4 SUPPLY CHAIN ECOSYSTEM 70
5.6 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 5 BIOINFORMATICS SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 72
5.6.1 THREAT OF NEW ENTRANTS 72
5.6.2 THREAT OF SUBSTITUTES 72
5.6.3 BARGAINING POWER OF SUPPLIERS 72
5.6.4 BARGAINING POWER OF BUYERS 72
5.6.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 72
5.7 COVID-19 IMPACT 73

6 BIOINFORMATICS SERVICES MARKET, BY TYPE 74

6.1 INTRODUCTION 75
TABLE 6 BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 75
6.2 SEQUENCING SERVICES 76
TABLE 7 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 76
TABLE 8 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 76
TABLE 9 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 77
TABLE 10 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 77
TABLE 11 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 78
6.2.1 WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY 78
6.2.1.1 Launch of advanced whole-genome sequencing services to drive market growth 78
TABLE 12 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY, BY REGION,
2019–2026 (USD MILLION) 78
6.2.2 EXOME ANALYSIS 79
6.2.2.1 Rising awareness of exome analysis services to drive market growth 79
TABLE 13 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR EXOME ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 79
6.2.3 TRANSCRIPTOME ANALYSIS 79
6.2.3.1 Application of transcriptomics in diagnostics and cancer research is increasing 79
TABLE 14 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR TRANSCRIPTOME ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 80
6.2.4 METAGENOMIC ANALYSIS 80
6.2.4.1 Application of metagenomics in human microbiome analysis
to drive market growth 80
TABLE 15 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR METAGENOMIC ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 80
6.2.5 CHIP-SEQ ANALYSIS 81
6.2.5.1 Increasing awareness about the advantages of ChIP-seq among professionals to drive market growth 81
TABLE 16 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR CHIP-SEQ ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 81
6.2.6 OTHER SEQUENCING SERVICES 81
TABLE 17 BIOINFORMATICS SEQUENCING SERVICES MARKET FOR OTHER SEQUENCING SERVICES, BY REGION, 2019–2026 (USD MILLION) 81
6.3 DATA ANALYSIS SERVICES 82
TABLE 18 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
TABLE 19 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 83
TABLE 20 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 84
TABLE 21 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 84
TABLE 22 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 85
6.3.1 DATA MINING 85
6.3.1.1 Development of advanced bioinformatics applications and algorithms based on data mining to drive market growth 85
TABLE 23 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR DATA MINING,
BY REGION, 2019–2026 (USD MILLION) 85
6.3.2 GENOMIC ANALYSIS 86
6.3.2.1 Growth in the amount of sequencing data and technological advancements in genomic analysis to drive market growth 86
TABLE 24 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR GENOMIC ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 86
6.3.3 PROTEOMIC ANALYSIS 86
6.3.3.1 Increasing focus on personalized medicine and outsourcing of proteomic studies to drive market growth 86
TABLE 25 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2019–2026 (USD MILLION) 87
6.3.4 VARIANT ANNOTATION AND DISCOVERY 87
6.3.4.1 Increasing research on mutation analysis to drive market growth 87
TABLE 26 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET FOR VARIANT ANNOTATION AND DISCOVERY, BY REGION, 2019–2026 (USD MILLION) 87
6.4 DRUG DISCOVERY SERVICES 88
6.4.1 ADVANCEMENTS IN PHARMACOGENOMICS TO DRIVE MARKET GROWTH 88
TABLE 27 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY SPECIALTY, 2019–2026 (USD MILLION) 88
TABLE 28 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 89
TABLE 29 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 89
TABLE 30 BIOINFORMATICS DRUG DISCOVERY SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 90
6.5 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES 90
6.5.1 R&D FOR THE ADVANCEMENT OF SOLUTIONS & SERVICES FOR DIFFERENTIAL GENE EXPRESSION STUDIES IS INCREASING 90
TABLE 31 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES MARKET, BY SPECIALTY, 2019–2026 (USD MILLION) 91
TABLE 32 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 91
TABLE 33 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET,
BY END USER, 2019–2026 (USD MILLION) 92
TABLE 34 BIOINFORMATICS DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET,
BY REGION, 2019–2026 (USD MILLION) 92
6.6 DATABASE AND MANAGEMENT SERVICES 92
6.6.1 GOVERNMENT INITIATIVES FOR DATA SHARING WILL DRIVE MARKET GROWTH 92
TABLE 35 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY SPECIALTY, 2019–2026 (USD MILLION) 93
TABLE 36 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 94
TABLE 37 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION) 94
TABLE 38 BIOINFORMATICS DATABASE AND MANAGEMENT SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 95
6.7 OTHER BIOINFORMATICS SERVICES 95
TABLE 39 OTHER BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 95
TABLE 40 OTHER BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 96
TABLE 41 OTHER BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 96
TABLE 42 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 96

7 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY 97

7.1 INTRODUCTION 98
TABLE 43 BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 98
7.2 MEDICAL BIOTECHNOLOGY 98
7.2.1 USE OF BIOINFORMATICS SERVICES IS INCREASING IN MOLECULAR MEDICINE, DRUG DISCOVERY, AND CLINICAL DIAGNOSTICS 98
TABLE 44 BIOINFORMATICS SERVICES MARKET FOR MEDICAL BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 99
7.3 ANIMAL BIOTECHNOLOGY 99
7.3.1 VAST OMICS DATABASES FOR SEQUENCING & ANALYSIS OF ANIMAL GENOMIC DATA ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT 99
TABLE 45 BIOINFORMATICS SERVICES MARKET FOR ANIMAL BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 100
7.4 PLANT BIOTECHNOLOGY 100
7.4.1 DECREASING SEQUENCING COST AND ADVANCED BIOINFORMATICS SERVICES TO BOOST MARKET GROWTH 100
TABLE 46 BIOINFORMATICS SERVICES MARKET FOR PLANT BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 101
7.5 ENVIRONMENTAL BIOTECHNOLOGY 101
7.5.1 R&D OF BIOINFORMATICS IN ENVIRONMENTAL BIOTECHNOLOGY TO DRIVE MARKET GROWTH 101
TABLE 47 BIOINFORMATICS SERVICES MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION, 2019–2026 (USD MILLION) 102
7.6 FORENSIC BIOTECHNOLOGY 102
7.6.1 IMPROVED USE OF FORENSIC BIOINFORMATICS WILL
DRIVE MARKET GROWTH 102
TABLE 48 BIOINFORMATICS SERVICES MARKET FOR FORENSIC BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 103

8 BIOINFORMATICS SERVICES MARKET, BY APPLICATION 104

8.1 INTRODUCTION 105
TABLE 49 BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 105
8.2 GENOMICS 105
8.2.1 GENOMICS IS THE LARGEST APPLICATION SEGMENT IN THE BIOINFORMATICS SERVICES MARKET 105
TABLE 50 BIOINFORMATICS SERVICES MARKET FOR GENOMICS, BY REGION,
2019–2026 (USD MILLION) 106
8.3 CHEMOINFORMATICS & DRUG DESIGN 106
8.3.1 PROACTIVE USE OF CHEMOINFORMATICS IN DRUG DISCOVERY BY PHARMACEUTICAL COMPANIES WILL DRIVE MARKET GROWTH 106
TABLE 51 BIOINFORMATICS SERVICES MARKET FOR CHEMOINFORMATICS & DRUG DESIGN, BY REGION, 2019–2026 (USD MILLION) 106
8.4 PROTEOMICS 107
8.4.1 R&D AND FINANCIAL SUPPORT FROM GOVERNMENT AND PRIVATE FUNDING BODIES IS INCREASING IN THE FIELD OF PROTEOMICS 107
TABLE 52 BIOINFORMATICS SERVICES MARKET FOR PROTEOMICS, BY REGION,
2019–2026 (USD MILLION) 107
8.5 TRANSCRIPTOMICS 108
8.5.1 INCREASING NUMBER OF RESEARCH STUDIES FOR THE TREATMENT OF CANCER USING TRANSCRIPTOMICS WILL SUPPORT MARKET GROWTH 108
TABLE 53 BIOINFORMATICS SERVICES MARKET FOR TRANSCRIPTOMICS, BY REGION, 2019–2026 (USD MILLION) 108
8.6 METABOLOMICS 108
8.6.1 TECHNOLOGICAL ADVANCEMENT IN THE FIELD OF METABOLOMICS AND DATA ANALYSIS TO DRIVE MARKET GROWTH 108
TABLE 54 BIOINFORMATICS SERVICES MARKET FOR METABOLOMICS, BY REGION, 2019–2026 (USD MILLION) 109
8.7 OTHER APPLICATIONS 109
TABLE 55 BIOINFORMATICS SERVICES MARKET FOR OTHER APPLICATIONS,
BY REGION, 2019–2026 (USD MILLION) 109

9 BIOINFORMATICS SERVICES MARKET, BY END USER 110

9.1 INTRODUCTION 111
TABLE 56 BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 111
9.2 ACADEMIC INSTITUTES AND RESEARCH CENTERS 111
9.2.1 ACADEMIC INSTITUTES AND RESEARCH CENTERS ARE THE LARGEST END USERS OF BIOINFORMATICS SERVICES 111
TABLE 57 BIOINFORMATICS SERVICES MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2019–2026 (USD MILLION) 113
9.3 HOSPITALS AND CLINICS 113
9.3.1 GROWING NUMBER OF COLLABORATIONS AND AGREEMENTS BETWEEN COMPANIES AND HOSPITALS TO BOOST MARKET GROWTH 113
TABLE 58 BIOINFORMATICS SERVICES MARKET FOR HOSPITALS AND CLINICS,
BY REGION, 2019–2026 (USD MILLION) 114
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 114
9.4.1 INCREASING FOCUS ON DEVELOPING TARGETED THERAPIES WILL DRIVE THE MARKET GROWTH 114
TABLE 59 BIOINFORMATICS SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 115
9.5 CONTRACT RESEARCH ORGANIZATIONS 115
9.5.1 INCREASING NUMBER OF CROS WILL ENHANCE THE MARKET GROWTH 115
TABLE 60 BIOINFORMATICS SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2026 (USD MILLION) 116
9.6 OTHER END USERS 116
TABLE 61 BIOINFORMATICS SERVICES MARKET FOR OTHER END USERS,
BY REGION, 2019–2026 (USD MILLION) 116

10 BIOINFORMATICS SERVICES MARKET, BY REGION 117

10.1 INTRODUCTION 118
TABLE 62 BIOINFORMATICS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 118
10.2 NORTH AMERICA 119
FIGURE 27 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET SNAPSHOT 120
TABLE 63 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 64 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 65 N0RTH AMERICA: BIOINFORMATICS SEQUENCING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 66 NORTH AMERICA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 67 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY, 2019–2026 (USD MILLION) 123
TABLE 68 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 123
TABLE 69 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 124
10.2.1 US 124
10.2.1.1 Growing R&D activities in the US to drive market growth 124
TABLE 70 US: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 71 US: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 72 US: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
10.2.2 CANADA 126
10.2.2.1 Increasing government initiatives in genomics research will boost the adoption of bioinformatics services 126
TABLE 73 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 74 CANADA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 75 CANADA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
10.3 EUROPE 128
TABLE 76 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 129
TABLE 77 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 78 EUROPE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 79 EUROPE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 80 EUROPE: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 131
TABLE 81 EUROPE: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 82 EUROPE: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 132
10.3.1 GERMANY 132
10.3.1.1 Funding initiatives by the government will drive market growth 132
TABLE 83 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 84 GERMANY: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 85 GERMANY: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
10.3.2 UK 134
10.3.2.1 UK dominates the bioinformatics services market in Europe 134
TABLE 86 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 87 UK: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 88 UK: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
10.3.3 FRANCE 136
10.3.3.1 Government initiatives to support genomics research—a major factor driving market growth in France 136
TABLE 89 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 90 FRANCE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 91 FRANCE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Favorable funding scenario to drive the bioinformatics services market in Italy 137
TABLE 92 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 93 ITALY: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 94 ITALY: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 139
10.3.5 SPAIN 139
10.3.5.1 Increasing number of conferences focusing on new sequencing technologies and data analysis to support market growth 139
TABLE 95 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 96 SPAIN: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 97 SPAIN: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
10.3.6 REST OF EUROPE 141
TABLE 98 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 99 ROE: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 100 ROE: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
10.4 ASIA PACIFIC 142
FIGURE 28 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET SNAPSHOT 143
TABLE 101 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 144
TABLE 102 APAC: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 103 APAC: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 104 APAC: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 105 APAC: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 145
TABLE 106 APAC: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 146
TABLE 107 APAC: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 146
10.4.1 JAPAN 146
10.4.1.1 Increasing focus on personalized diagnostics products to drive market growth in Japan 146
TABLE 108 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 109 JAPAN: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 110 JAPAN: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 148
10.4.2 CHINA 148
10.4.2.1 China is the largest market for bioinformatics services in APAC 148
TABLE 111 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 112 CHINA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 113 CHINA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
10.4.3 INDIA 150
10.4.3.1 Growing prevalence of target diseases in India to support market growth 150
TABLE 114 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 115 INDIA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 116 INDIA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
10.4.4 AUSTRALIA 152
10.4.4.1 Increasing use of NGS platforms by academic institutes to propel market growth 152
TABLE 117 AUSTRALIA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 118 AUSTRALIA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 119 AUSTRALIA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
10.4.5 SOUTH KOREA 154
10.4.5.1 Supportive government initiatives expected to positively impact market growth 154
TABLE 120 SOUTH KOREA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 121 SOUTH KOREA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 122 SOUTH KOREA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 156
10.4.6 REST OF ASIA PACIFIC 156
TABLE 123 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 124 ROAPAC: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 125 ROAPAC: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
10.5 LATIN AMERICA 157
TABLE 126 LATAM: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
TABLE 127 LATAM: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 128 LATAM: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 129 LATAM: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 130 LATAM: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 159
TABLE 131 LATAM: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 160
TABLE 132 LATAM: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 160
10.5.1 BRAZIL 160
10.5.1.1 Focus on NGS technologies and NGS data analysis is
increasing in Brazil 160
TABLE 133 BRAZIL: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 134 BRAZIL: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 135 BRAZIL: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
10.5.2 MEXICO 162
10.5.2.1 Economic growth in Mexico to support the growth of the market 162
TABLE 136 MEXICO: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 137 MEXICO: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 138 MEXICO: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 163
10.5.3 REST OF LATIN AMERICA 163
TABLE 139 ROLA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 140 ROLA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 141 ROLA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
10.6 MIDDLE EAST & AFRICA 165
10.6.1 INCREASING FOCUS ON GENOMICS RESEARCH TO DRIVE MARKET GROWTH IN MEA 165
TABLE 142 MEA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 143 MEA: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 144 MEA: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 145 MEA: BIOINFORMATICS SERVICES MARKET, BY SPECIALTY,
2019–2026 (USD MILLION) 167
TABLE 146 MEA: BIOINFORMATICS SERVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
TABLE 147 MEA: BIOINFORMATICS SERVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 168

11 COMPETITIVE LANDSCAPE 169

11.1 OVERVIEW 169
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 169
11.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOINFORMATICS SERVICE PROVIDERS 170
11.4 REVENUE ANALYSIS 171
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE BIOINFORMATICS SERVICES MARKET 171
11.5 MARKET SHARE ANALYSIS 171
FIGURE 30 THERMO FISHER SCIENTIFIC HELD THE LEADING POSITION IN THE BIOINFORMATICS SERVICES MARKET IN 2020 172
11.6 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 173
11.7 VENDOR INCLUSION CRITERIA 173
11.7.1 STARS 173
11.7.2 PERVASIVE PLAYERS 173
11.7.3 EMERGING LEADERS 174
11.7.4 PARTICIPANTS 174
FIGURE 31 BIOINFORMATICS SERVICES MARKET: GLOBAL COMPANY
EVALUATION MATRIX, 2020 174
11.8 COMPANY EVALUATION QUADRANT (SMES/STRAT-UPS) 175
11.8.1 PROGRESSIVE COMPANIES 175
11.8.2 STARTING BLOCKS 175
11.8.3 RESPONSIVE COMPANIES 175
11.8.4 DYNAMIC COMPANIES 175
FIGURE 32 BIOINFORMATICS SERVICES MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2020 (SME/START-UPS) 176
11.9 COMPETITIVE BENCHMARKING 177
FIGURE 33 SERVICE AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BIOINFORMATICS SERVICES MARKET 177
TABLE 148 SERVICE FOOTPRINT OF COMPANIES 177
TABLE 149 REGIONAL FOOTPRINT OF COMPANIES 178
11.10 COMPETITIVE SCENARIO AND TRENDS 178
TABLE 150 BIOINFORMATICS SERVICES MARKET: SERVICE LAUNCHES,
JANUARY 2017–MAY 2021 178
TABLE 151 BIOINFORMATICS SERVICES MARKET: EXPANSIONS,
JANUARY 2017–MAY 2021 179
TABLE 152 BIOINFORMATICS SERVICES MARKET: DEALS, JANUARY 2017–MAY 2021 179

12 COMPANY PROFILES 181

12.1 KEY PLAYERS 181
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC 181
TABLE 153 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW 181
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 182
TABLE 154 THERMO FISHER SCIENTIFIC: SERVICE OFFERINGS 182
TABLE 155 THERMO FISHER SCIENTIFIC: DEALS 183
TABLE 156 THERMO FISHER SCIENTIFIC: OTHER DEVELOPMENTS 184
12.1.2 EUROFINS SCIENTIFIC 186
TABLE 157 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 186
FIGURE 35 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 187
TABLE 158 EUROFINS SCIENTIFIC: SERVICE OFFERINGS 187
TABLE 159 EUROFINS SCIENTIFIC: SERVICE LAUNCHES 188
TABLE 160 EUROFINS SCIENTIFIC: DEALS 188
12.1.3 ILLUMINA 190
TABLE 161 ILLUMINA: BUSINESS OVERVIEW 190
FIGURE 36 ILLUMINA: COMPANY SNAPSHOT 191
TABLE 162 ILLUMINA: SERVICE OFFERINGS 191
TABLE 163 ILLUMINA: DEALS 192
TABLE 164 ILLUMINA: OTHER DEVELOPMENTS 194
12.1.4 PERKINELMER 196
TABLE 165 PERKINELMER: BUSINESS OVERVIEW 196
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT 197
TABLE 166 PERKINELMER: SERVICE OFFERINGS 197
TABLE 167 PERKINELMER: SERVICE LAUNCHES 198
TABLE 168 PERKINELMER: DEALS 198
12.1.5 NEOGENOMICS 200
TABLE 169 NEOGENOMICS: BUSINESS OVERVIEW 200
FIGURE 38 NEOGENOMICS: COMPANY SNAPSHOT 200
TABLE 170 NEOGENOMICS: SERVICE OFFERINGS 201
TABLE 171 NEOGENOMICS: OTHER DEVELOPMENTS 201
12.1.6 BASECLEAR 202
TABLE 172 BASECLEAR: BUSINESS OVERVIEW 202
TABLE 173 BASECLEAR: SERVICE OFFERINGS 202
TABLE 174 BASECLEAR: SERVICE LAUNCHES 203
TABLE 175 BASECLEAR: DEALS 203
TABLE 176 BGI GROUP: BUSINESS OVERVIEW 204
TABLE 177 BGI GROUP: SERVICE OFFERINGS 205
TABLE 178 BGI GROUP: DEALS 206
12.1.8 CD GENOMICS 208
TABLE 179 CD GENOMICS: BUSINESS OVERVIEW 208
TABLE 180 CD GENOMICS: SERVICE OFFERINGS 208
12.1.9 FIOS GENOMICS 209
TABLE 181 FIOS GENOMICS: BUSINESS OVERVIEW 209
TABLE 182 FIOS GENOMICS: SERVICE OFFERINGS 209
TABLE 183 FIOS GENOMICS: DEALS 210
12.1.10 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY) 211
TABLE 184 GENEWIZ: BUSINESS OVERVIEW 211
FIGURE 39 BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT 212
TABLE 185 GENEWIZ: SERVICE OFFERINGS 212
TABLE 186 GENEWIZ: SERVICE LAUNCHES 213
TABLE 187 GENEWIZ: DEALS 213
TABLE 188 GENEWIZ: OTHER DEVELOPMENTS 213
12.1.11 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN) 214
TABLE 189 PSOMAGEN, INC.: BUSINESS OVERVIEW 214
TABLE 190 PSOMAGEN: SERVICE OFFERINGS 214
TABLE 191 PSOMAGEN: DEALS 216
TABLE 192 PSOMAGEN: OTHER DEVELOPMENTS 216
12.1.12 MEDGENOME LABS 217
TABLE 193 MEDGENOME: BUSINESS OVERVIEW 217
TABLE 194 MEDGENOME: SERVICE OFFERINGS 217
12.1.13 MICROSYNTH 218
TABLE 195 MICROSYNTH: BUSINESS OVERVIEW 218
TABLE 196 MICROSYNTH: SERVICE OFFERINGS 218
TABLE 197 MICROSYNTH: SERVICE LAUNCHES 219
12.1.14 QIAGEN N.V. 220
TABLE 198 QIAGEN N.V.: BUSINESS OVERVIEW 220
FIGURE 40 QIAGEN N.V.: COMPANY SNAPSHOT 221
TABLE 199 QIAGEN N.V.: SERVICE OFFERINGS 221
TABLE 200 QIAGEN N.V.: DEALS 222
TABLE 201 QIAGEN N.V.: OTHER DEVELOPMENTS 223
12.1.15 SOURCE BIOSCIENCE 224
TABLE 202 SOURCE BIOSCIENCE: BUSINESS OVERVIEW 224
FIGURE 41 SOURCE BIOSCIENCE: COMPANY SNAPSHOT 225
TABLE 203 SOURCE BIOSCIENCE: SERVICE OFFERINGS 225
12.2 OTHER COMPANIES 227
12.2.1 NXT-DX (A DIAGENODE COMPANY) 227
12.2.2 NUCLEOME BIOINFORMATICS 228
12.2.3 1010GENOME 229
12.2.4 DNANEXUS, INC. 229
12.2.5 BIONIVID 230
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX 231

13.1 DISCUSSION GUIDE 231
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 236
13.3 AVAILABLE CUSTOMIZATIONS 238
13.4 RELATED REPORTS 238
13.5 AUTHOR DETAILS 239



お問合せフォーム

    ※レポートのタイトルは自動で入ります。

    お名前(必須)

    会社名(必須)

    部署名

    メールアドレス(必須)

    電話番号

    ご用件(必須)

    お問合わせ内容(必須)

     

    ※プライバシーポリシーはこちらをご確認ください。

    当ウェブサイトを知った経由を教えてください。

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    プライバシーポリシーはこちらをご覧ください。